Fuchs endothelial dystrophy
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Fuchs endothelial dystrophy is a condition that causes vision problems. The first symptom of this condition is typically blurred vision in the morning that usually clears during the day. Over time, affected individuals lose the ability to see details (visual acuity). People with Fuchs endothelial dystrophy also become sensitive to bright lights.
Video picks for Genetic conditionsVideo library
Description
Fuchs endothelial dystrophy is a condition that causes vision problems. The first symptom of this condition is typically blurred vision in the morning that usually clears during the day. Over time, affected individuals lose the ability to see details (visual acuity). People with Fuchs endothelial dystrophy also become sensitive to bright lights.
Fuchs endothelial dystrophy specifically affects the front surface of the eye called the cornea. Deposits called guttae, which are detectable during an eye exam, form in the middle of the cornea and eventually spread throughout the cornea. These guttae contribute to the ongoing cell death within the cornea, leading to worsening vision problems. Tiny blisters may develop on the cornea, which can burst and cause eye pain.
The signs and symptoms of Fuchs endothelial dystrophy usually begin in a person's forties or fifties. A very rare early-onset variant of this condition starts to affect vision in a person's twenties.
Inheritance patterns
The source lists the following possible inheritance patterns: Pattern unknown; Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
Fuchs atrophy
Fuchs corneal dystrophy
Fuchs dystrophy
Fuchs endothelial corneal dystrophy
Fuchs' endothelial dystrophy
Patient picks for Genetic conditions

Bones, joints and muscles
Muscular dystrophy
Muscular dystrophy is an inherited (genetic) disorder causing muscle weakness. There are different types of muscular dystrophy, which vary as to how severe they are, ranging from very mild to severe. The different types also vary as to what age they begin. If muscular dystrophy is suspected, tests can help to make an accurate diagnosis. Other people in the family can also be tested to see if they have a muscular dystrophy gene. Muscular dystrophy cannot be cured but there are various treatments which can help.
by Dr Doug McKechnie, MRCGP

Children's health
Duchenne muscular dystrophy
Duchenne muscular dystrophy is a condition which causes progressive muscle weakness. It starts in childhood and may be noticed when a child has difficulty standing up, climbing or running. It is a genetic condition and can be inherited. It usually affects only boys, although girls may carry the Duchenne gene. Boys with Duchenne muscular dystrophy should have regular reviews and physiotherapy from childhood. They are likely to need increasing help and treatments.
by Dr Philippa Vincent, MRCGP
Related patient information and medicines

Patient information leaflet
Visual problems
This leaflet describes most eye conditions which can affect vision, either temporarily or permanently. Endophthalmitis Endophthalmitis is a term for a catastrophic eye infection - that is, bacterial infection of the g... Retinal dystrophy Retinal dystrophies are a group of inherited (genetic) disorders which result in changes to the retina which.

Patient information leaflet
Flat feet and fallen arches
Some conditions affecting the nerves such as cerebral palsy Cerebral palsy , Parkinson's disease Parkinson's disease and muscular dystrophy Duchenne muscular dystrophy , in which muscles become stiffer and weaker over time. Rar... Treatments may include fusing bones, removing pieces of bony growth (spurs), tendon enhancement surgery and bone.

Patient information leaflet
Retinal vein occlusion
Retinal vein occlusion occurs when one of the tiny veins in the retina becomes blocked by a blood clot. What is reti... A number of different treatments are used with the aim of reducing the swelling, so that the retina can recover. The earlier this is done, the better the chance of some recovery: Anti-vascular endothelial growth factor.

Patient information leaflet
Eye problems
This leaflet contains a list of conditions which affect the eye, grouped together by the part of the eye which is affected or involved. ... Corneal dystrophies These are a group of progressive conditions which cause a build-up of cloudy material in the cornea. Retinal dystrophy Retinal dystrophies are a group of inherited disorders which result in.

Patient information leaflet
Genetic testing
Genetic testing is a type of medical test that identifies changes in chromosomes, genes or proteins. Genetic tests examine a person's DNA in a variety of ways to assess a person's genetic health. Fluorescent in situ hybridisation (FISH) analysis - this test looks at certain parts of the chromosomes and can detect very small pieces of chromosomes.

Patient information leaflet
Macular degeneration
Macular degeneration (also known as age-related macular degeneration) occurs when cells in the macula - the central area of the retina - degenerate. Intraocular lens systems (see below) are a recent development which may ... Treatment for wet AMD For the less common wet AMD, a treatment called anti-vascular endothelial growth factor (anti-VEGF).
Further reading and references
- Fuchs endothelial dystrophy; MedlinePlus, National Library of Medicine.
- Afshari NA, Igo RP Jr, Morris NJ, Stambolian D, Sharma S, Pulagam VL, Dunn S, Stamler JF, Truitt BJ, Rimmler J, Kuot A, Croasdale CR, Qin X, Burdon KP, Riazuddin SA, Mills R, Klebe S, Minear MA, Zhao J, Balajonda E, Rosenwasser GO, Baratz KH, Mootha VV, Patel SV, Gregory SG, Bailey-Wilson JE, Price MO, Price FW Jr, Craig JE, Fingert JH, Gottsch JD, Aldave AJ, Klintworth GK, Lass JH, Li YJ, Iyengar SK. Genome-wide association study identifies three novel loci in Fuchs endothelial corneal dystrophy. Nat Commun. 2017 Mar 30;8:14898. doi: 10.1038/ncomms14898.
- Afshari NA, Li YJ, Pericak-Vance MA, Gregory S, Klintworth GK. Genome-wide linkage scan in fuchs endothelial corneal dystrophy. Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1093-7. doi: 10.1167/iovs.08-1839. Epub 2008 May 23.
- Baratz KH, Tosakulwong N, Ryu E, Brown WL, Branham K, Chen W, Tran KD, Schmid-Kubista KE, Heckenlively JR, Swaroop A, Abecasis G, Bailey KR, Edwards AO. E2-2 protein and Fuchs's corneal dystrophy. N Engl J Med. 2010 Sep 9;363(11):1016-24. doi: 10.1056/NEJMoa1007064. Epub 2010 Aug 25.
- Biswas S, Munier FL, Yardley J, Hart-Holden N, Perveen R, Cousin P, Sutphin JE, Noble B, Batterbury M, Kielty C, Hackett A, Bonshek R, Ridgway A, McLeod D, Sheffield VC, Stone EM, Schorderet DF, Black GC. Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet. 2001 Oct 1;10(21):2415-23. doi: 10.1093/hmg/10.21.2415.
- Eghrari AO, Gottsch JD. Fuchs' corneal dystrophy. Expert Rev Ophthalmol. 2010 Apr;5(2):147-159. doi: 10.1586/eop.10.8.
- Gottsch JD, Sundin OH, Liu SH, Jun AS, Broman KW, Stark WJ, Vito EC, Narang AK, Thompson JM, Magovern M. Inheritance of a novel COL8A2 mutation defines a distinct early-onset subtype of fuchs corneal dystrophy. Invest Ophthalmol Vis Sci. 2005 Jun;46(6):1934-9. doi: 10.1167/iovs.04-0937.
- Riazuddin SA, Vithana EN, Seet LF, Liu Y, Al-Saif A, Koh LW, Heng YM, Aung T, Meadows DN, Eghrari AO, Gottsch JD, Katsanis N. Missense mutations in the sodium borate cotransporter SLC4A11 cause late-onset Fuchs corneal dystrophy. Hum Mutat. 2010 Nov;31(11):1261-8. doi: 10.1002/humu.21356. Epub 2010 Oct 14.
- Riazuddin SA, Zaghloul NA, Al-Saif A, Davey L, Diplas BH, Meadows DN, Eghrari AO, Minear MA, Li YJ, Klintworth GK, Afshari N, Gregory SG, Gottsch JD, Katsanis N. Missense mutations in TCF8 cause late-onset Fuchs corneal dystrophy and interact with FCD4 on chromosome 9p. Am J Hum Genet. 2010 Jan;86(1):45-53. doi: 10.1016/j.ajhg.2009.12.001. Epub 2009 Dec 31.
- Vithana EN, Morgan PE, Ramprasad V, Tan DT, Yong VH, Venkataraman D, Venkatraman A, Yam GH, Nagasamy S, Law RW, Rajagopal R, Pang CP, Kumaramanickevel G, Casey JR, Aung T. SLC4A11 mutations in Fuchs endothelial corneal dystrophy. Hum Mol Genet. 2008 Mar 1;17(5):656-66. doi: 10.1093/hmg/ddm337. Epub 2007 Nov 16.
- Wright AF, Dhillon B. Major progress in Fuchs's corneal dystrophy. N Engl J Med. 2010 Sep 9;363(11):1072-5. doi: 10.1056/NEJMe1007495. Epub 2010 Aug 25. No abstract available.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

